The Food and Drug Administration (FDA) has been approving new and often risky drugs at an increasingly fast rate, a practice some experts believe is hurting more than helping patients. The MS drug Gilenya is one of three cited, and has had negative effects on heart rate. The drug has already been met with “seven major safety issues.”


Article Says Agency Let Risky Drugs Hit Market
online.wsj.com
An FDA effort to speed approval of new medicines allowed drugs onto the market without proper safety analysis, according to two drug-safety experts.